Powered by

FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief; Products Listing CBD as Inactive Ingredient Cited for Unapproved Drug and Misbranding Violations

Mar 22, 2021 - PR Newswire

PR Newswire

The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal marketing of unapproved drugs labeled as containing CBD. The FDA has not approved any over-the-counter (OTC) drugs containing CBD, and none of these products meet the requirements to be legally marketed without ...